These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients. Ghadirian AM; Annable L; Bélanger MC; Chouinard G J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543 [TBL] [Abstract][Full Text] [Related]
3. The challenge of predicting response to stabilising lithium treatment. The importance of patient selection. Grof P; Alda M; Grof E; Fox D; Cameron P Br J Psychiatry Suppl; 1993 Sep; (21):16-9. PubMed ID: 8217062 [TBL] [Abstract][Full Text] [Related]
4. Effect of phenytoin on mood and declarative memory during prescription corticosteroid therapy. Brown ES; Stuard G; Liggin JD; Hukovic N; Frol A; Dhanani N; Khan DA; Jeffress J; Larkin GL; McEwen BS; Rosenblatt R; Mageto Y; Hanczyc M; Cullum CM Biol Psychiatry; 2005 Mar; 57(5):543-8. PubMed ID: 15737670 [TBL] [Abstract][Full Text] [Related]
5. Relationship between prophylactic effect of lithium therapy and family history of affective disorders. Engström C; Aström M; Nordqvist-Karlsson B; Adolfsson R; Nylander PO Biol Psychiatry; 1997 Sep; 42(6):425-33. PubMed ID: 9285078 [TBL] [Abstract][Full Text] [Related]
6. [Lithium and hypothyroidism]. Filion M; Hillel J Union Med Can; 1985 Nov; 114(11):929-31, 933. PubMed ID: 4090097 [No Abstract] [Full Text] [Related]
7. [Prophylactic treatment of mood disorders: cost effectiveness analysis comparing lithium and carbamazepine]. Dardennes R; Lafuma A; Watkins S Encephale; 1999; 25(5):391-400. PubMed ID: 10598301 [TBL] [Abstract][Full Text] [Related]
8. Neurological sequelae of lithium therapy. Mahy Ge West Indian Med J; 1984 Dec; 33(4):272-4. PubMed ID: 6523856 [No Abstract] [Full Text] [Related]
10. Lithium in the prophylaxis of affective disorders: a twenty years experience. Hanus H; Zapletálek M; Kindernayová H; Tůma I Act Nerv Super (Praha); 1989 Apr; 31(1):27. PubMed ID: 2781994 [No Abstract] [Full Text] [Related]
11. Reduced plasma cyclic AMP level during prophylactic lithium treatment in patients with affective disorders. Arató M; Rihmer Z; Felszeghy K Biol Psychiatry; 1980 Apr; 15(2):319-22. PubMed ID: 6251928 [No Abstract] [Full Text] [Related]
13. Lithium ratio, phospholipids and the incidence of side effects. De Maio D; Buffa G; Riva M; Laviani M; Levi-Minzi A Prog Neuropsychopharmacol Biol Psychiatry; 1994 Mar; 18(2):285-93. PubMed ID: 8208979 [TBL] [Abstract][Full Text] [Related]
15. The long term prophylaxis of affective disorders. Koukopoulos A; Reginaldi D; Minnai G; Serra G; Pani L; Johnson FN Adv Biochem Psychopharmacol; 1995; 49():127-47. PubMed ID: 7653332 [No Abstract] [Full Text] [Related]
16. [Further considerations on the use of lithium carbonate and the renal and thyroid disorders resulting from it]. Chouinard G Union Med Can; 1980 Feb; 109(2):221-6, 304. PubMed ID: 6774458 [No Abstract] [Full Text] [Related]
17. Psychotherapies and somatic therapies in affective disorders. Klerman GL Psychiatr Clin North Am; 1983 Mar; 6(1):85-103. PubMed ID: 6889177 [No Abstract] [Full Text] [Related]
18. Subjective side effects of lithium carbonate: a longitudinal study. Duncavage MB; Nasr SJ; Altman EG J Clin Psychopharmacol; 1983 Apr; 3(2):100-2. PubMed ID: 6404952 [No Abstract] [Full Text] [Related]
19. The impact of lithium in South-west Scotland. I. Demographic and clinical findings. McCreadie RG; Morrison DP Br J Psychiatry; 1985 Jan; 146():70-4. PubMed ID: 3872149 [TBL] [Abstract][Full Text] [Related]
20. [The use of carbamazepine in affective disorders]. Beresewicz M Psychiatr Pol; 1994; 28(4):455-66. PubMed ID: 7972553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]